Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/614451


ev3 Inc. - Healthcare - Medical Equipment SWOT Report


Description: ev3 Inc. - Healthcare - Medical Equipment SWOT Report is a comprehensive report of the company including both quantitative and qualitative research. The report examines the company’s business structure and operations, history and products. The report provides strategic insight on the company in the form of a SWOT analysis. This studies the major internal factors which will affect the company’s performance e.g. size, strength, cost, revenues and strategy as well as external factors e.g. competitive positioning and industry trends. There is a forward-looking discussion of the opportunities the company can exploit and the threats facing it.

Scope

- Critical appraisal of the company’s positioning using SWOT analysis.
- Company information, including business descriptions, company history, product lines, key competitors and key employee biographies.

Reasons to buy

- Support business/sales activities by understanding customers businesses better.
- Identify prospective partners and suppliers.
- Capitalize on your competitors weaknesses and target the market opportunities available to them.


Contents: 1 3
1.1 List of Tables 6
2 Company Snapshot 7
2.1 Key Information 7
2.2 Company Overview 7
2.3 Financial Performance 7
2.4 Industry Outlook - Cardiovascular Devices 7
3 Business Description 8
3.1 Business Overview 8
3.2 Neurovascular Segment 8
3.2.1 Overview 8
3.2.2 Financials 8
3.2.3 Market View 8
3.2.4 Key Strategies 8
3.3 Peripheral Vascular Segment 8
3.3.1 Overview 8
3.3.2 Financials 9
3.3.3 Market View 9
3.3.4 Key Strategies 9
3.4 Major Products and Services 9
3.4.1 Overview 9
4 History 11
5 SWOT Analysis 12
5.1 Overview 12
5.2 ev3 Inc. Strengths 12
5.2.1 Consistent Revenue Growth 12
5.2.2 Sturdy Research Activities 12
5.2.3 Huge Product Range 13
5.3 ev3 Inc. Weaknesses 13
5.3.1 Reliance on Self-expanding Stents 13
5.3.2 Confined Manufacturing Facilities 13
5.4 ev3 Inc. Opportunities 13
5.4.1 Acquisitions 13
5.4.2 Product Approvals 13
5.4.3 Contracts by Novation 14
5.5 ev3 Inc. Threats 14
5.5.1 Intense Competition 14
5.5.2 Industry Consolidation 14
5.5.3 Intellectual Property Claims 14
6 Competitors 15
7 Key Employees 16
8 Key Employee Biographies 17
9 Company Statement 19
10 Locations And Subsidiaries 22
10.1 Head Office 22
10.2 Other Locations & Subsidiaries 22
11 Recent Developments 24
11.1 Financial Announcements 24
11.1.1 Jul 28, 2008: ev3 Reports 2Q 2008 Results 24
11.1.2 May 02, 2008: ev3 Reports Q1 2008 Results 26
11.1.3 Apr 18, 2008: ev3 To Declare Q1 2008 Results 27
11.1.4 Feb 22, 2008: ev3 Reports Q4 2007 Results 27
11.1.5 Feb 08, 2008: ev3 To Declare Q4 And 2007 Results 29
11.1.6 Jan 07, 2008: ev3 Reports Preliminary Q4 2007 Results and Revised 2008 Guidance 29
11.1.7 Oct 31, 2007: ev3 Reports Q3 2007 Results 30
11.1.8 Jul 22, 2007: ev3 Reports Q2 2007 Results 32
11.1.9 Apr 27, 2007: ev3 Reports Q1 2007 Results 34
11.1.10 Feb 20, 2007: ev3 Reports Year-End 2006 Results 35
11.1.11 Oct 20, 2006: ev3 Reports Q3 2006 Results 36
11.1.12 Jul 28, 2006: ev3 Reports Q2 2006 Results 37
11.2 Corporate Communications 39
11.2.1 Aug 04, 2008: ev3 Appoints New Board Member 39
11.2.2 Jul 21, 2008: ev3 Announces Management Changes 39
11.2.3 Apr 07, 2008: ev3 Announces Management Changes 39
11.2.4 Feb 08, 2008: ev3 Chief Scientist And Board Member Resigns 40
11.2.5 Feb 27, 2007: ev3 Appoints New Director 40
11.3 Product News 41
11.3.1 Dec 18, 2007: ev3 Introduces New Enhanced Offering For The Treatment Of Peripheral Artery Disease 41
11.3.2 Dec 18, 2007: ev3 Introduces New Enhanced Offerings For The Treatment Of Peripheral Artery Disease 41
11.3.3 Jun 04, 2007: ev3 Receives Conditional IDE Approval To Study Use Of Protégé EverFlex Self-Expanding Stent System In The Treatment Of Peripheral Artery Disease 41
11.3.4 Feb 15, 2006: SilverHawk Plaque Excision Shown To Minimize The Amputation Rate In Multi-Center Publication Of Patients With Critical Limb Ischemia 42
11.3.5 Apr 11, 2003: Early Results Show PLAATO Device Safe And Feasible For Stroke Prevention In Patients With Atrial Fibrillation 42
11.4 Product Approvals 42
11.4.1 Jun 04, 2007: ev3 Receives Conditional IDE Approval To Study Use Of Protégé EverFlex Self-Expanding Stent System In The Treatment Of Peripheral Artery Disease 42
11.5 Clinical Trials 43
11.5.1 Feb 15, 2006: SilverHawk Plaque Excision Shown To Minimize The Amputation Rate In Multi-Center Publication Of Patients With Critical Limb Ischemia 43
11.5.2 Apr 11, 2003: Early Results Show PLAATO Device Safe And Feasible For Stroke Prevention In Patients With Atrial Fibrillation 43
12 Appendix 44
12.1 Methodology 44
12.2 About us44
12.3 Contact Us 44
12.4 Disclaimer 44

Executive Summary

1.1 List of Tables
Table 1: ev3 Inc.,Key Facts, 2007 6
Table 2: ev3 Inc., SWOT Analysis , 2007 6
Table 3: ev3 Inc., Key Employees, 2007 6
Table 4: ev3 Inc., Other Locations 6
Table 5: ev3 Inc., Subsidiaries 6


Companies Mentioned The following companies are the major competitors of ev3 Inc.: Abbott Laboratories Balt Extrusion Boston Scientific Corporation C.R. Bard, Inc. Cook Group Incorporated Cordis Corporation Medtronic, Inc. Micrus Endovascular Corporation Possis Medical, Inc. Terumo Corporation The Spectranetics Corporation LeMaitre Vascular, Inc.


Ordering: Order Online - visit http://www.researchandmarkets.com/reports/614451

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 11/10/2008 15:32:36
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
ev3 Inc. - Healthcare - Medical Equipment SWOT Report
Web Address:
http://www.researchandmarkets.com/reports/614451
Office Code:
OCHKEOIPNTR

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User €92.00
Electronic (PDF) - Site License €185.00
Electronic (PDF) - Enterprisewide €277.00




Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 11/10/2008 15:32:36

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World